OMA Fellows contribute to PTCOG

Published on

The Particle Therapy Co-Operative Group (PTCOG) conference took place in Manchester, UK between 10-15 June 2019. PTCOG brings together leading clinicians, physicists and other practitioners in particle therapy to share the latest clinical, scientific and industrial developments and showcase the latest technology which can help patients.

The North West of England’s heritage as a pioneering region in cancer research and treatment for more than 100 years played a key part in bringing this important conference to the UK. This year also marks the 100th anniversary of Rutherford’s 1919 breakthrough in understanding the structure of the atom and discovering the proton – and Manchester was the perfect place to celebrate this anniversary.

The conference, held at Manchester Central, coincided with the opening of the first NHS high energy proton beam therapy centre at The Christie in December 2018 and was thus extremely timely.

Several OMA Fellows contributed to the conference programme through poster contributions. This included a poster by Laurent Kelleter (UCL) on a scintillator-based range telescope for quality assurance in particle therapy, end-to-end simulations of the Clatterbridge eye proton therapy beamline by Jacinta Yap, as well as a contribution on implementation and first tests of the CNAO dose delivery system at GSI by M. Lis (GSI). A particular highlight was an oral contribution by our Fellow Liheng Tian (LMU) on a new treatment planning concept accounting for in-vivo range verification in proton therapy. PTCOG59 will take place 9-14 May 2020 in Taipai, Taiwan.


More information about the conference can be found on the event website:

https://ptcog58.org/